Association of gene polymorphisms for plasminogen activators with alveolar bone loss

Journal of Periodontal Research

Volumn 42, Issue 4, 2007, Pages 305-310

  DeCarlo, A A ^a,c   Grenett, H ^b   Park, J ^a   Balton, W ^a   Cohen, J ^a   Hardigan, P ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Genotype; Periodontitis; Plasminogen activator; Plasminogen activator inhibitor type 1; Polymorphism; Urokinase

Indexed keywords

DNA MODIFICATION METHYLASE HINDIII; PLASMINOGEN ACTIVATOR INHIBITOR 1; SITE SPECIFIC DNA METHYLTRANSFERASE (ADENINE SPECIFIC); TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG; UROKINASE;

AGED; ALLELE; ARTICLE; CHRONIC DISEASE; EPIDEMIOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOLYSIS; RADIOGRAPHY; SMOKING;

AGED; AGED, 80 AND OVER; ALLELES; ALVEOLAR BONE LOSS; CHRONIC DISEASE; DEOXYRIBONUCLEASE BAMHI; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; SITE-SPECIFIC DNA-METHYLTRANSFERASE (ADENINE-SPECIFIC); SMOKING; URINARY PLASMINOGEN ACTIVATOR;

EID: 34250216057     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2006.00949.x     Document Type: Article

References (31)

1. Mazzieri R, Masiero L, Zanetta L et al. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO 1997 16 : 2319 2332.
2. Mignatti P, Rifkin DB. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 1996 49 : 117 137.
3. Hidaka N, Maeda K, Kawakami C, Aono M, Okada H. Fibrinolytic activity in periodontal disease. The relationship between fibrinolytic activity and severity of periodontal disease. J Periodontol 1981 52 : 181 186.
4. Kaslick RS, Chasens AI, Innerfield I, Rowley GR. Tissue plasminogen in normal and inflamed human gingiva. J Dent Res 1969 48 : 603.
5. Schmid J, Chambers DA. Molecular characterization of plasminogen activator in human supragingival plaque. Arch Oral Biol 1989 34 : 17 21.
6. Brown JM, Watanabe K, Cohen RL, Chambers DA. Molecular characterization of plasminogen activators in human gingival crevicular fluid. Arch Oral Biol 1995 40 : 839 845.
7. Pinchback JS, Gibbins JR, Hunter N. Vascular co-localization of proteolytic enzymes and proteinase inhibitors in advanced periodontitis. J Pathol 1996 179 : 326 332.
8. Kinnby B, Lindberg P, Lecander I, Matsson L. Localization of plasminogen activators and plasminogen-activator inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization. Arch Oral Biol 1999 44 : 1027 1034.
9. Izakovicova HL, Buckova D, Fassmann A, Benes P, Znojil V. Plasminogen-activator-inhibitor-1 promoter polymorphism as a risk factor for adult periodontitis in non-smokers. Genes Immun 2002 3 : 292 294.
10. Foy CA, Grant PJ. PCR-RFLP detection of PAI-2 gene variants: prevalence in ethnic groups and disease relationship in patients undergoing coronary angiography. Thromb Haemost 1997 77 : 955 958.
11. Grenett HE, Reeder VC, Li X-N, Benza RL, Hines RB, Booyse FM. Identification of a BamHI polymorphism for the urokinase gene associated with symptomatic coronary artery disease. J Thromb Thrombolysis 1998 5 : 113 118.
12. Benza RL, Grenett H, Li XN et al. Gene polymorphisms for PAI-1 are associated with angiographic extent of coronary artery disease. J Thromb Thrombolysis 1998 5 : 143 150.
13. Benza RL, Grenett HE, Bourge RC et al. Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease. Circulation 1998 98 : 2248 2254.
14. Nagi DK, McCormack LJ, Mohamed-Ali V, Yudkin JS, Knowler WC, Grant PJ. Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes. Diabetes Care 1997 20 : 1304 1309.
15. Iwai N, Shimoike H, Nakamura Y, Tamaki S, Kinoshita M. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes. Atherosclerosis 1998 136 : 109 114.
16. Grubic N, Stegnar M, Peternel P, Kaider A, Binder BR. A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis. Thromb Res 1996 84 : 431 443.
17. Sell SM, Blasi F, Booyse F. Automated, PCR-RFLP genotyping of the urokinase gene. Genet Test 2000 4 : 305 307.
18. Grenett HE, Khan N, Jiang W, Booyse FM. Identification of the HindIII polymorphic site in the PAI-1 gene: analysis of the PAI-1 HindIII polymorphism by PCR. Genet Test 2000 4 : 65 68.
19. Pastinen T, Ge B, Hudson TJ. Influence of human genome polymorphism on gene expression. Hum Mol Genet 2006 15 : R9 R16.
20. Murata T, Nakashima Y, Yasunaga C, Maeda K, Sueishi K. Extracellular and cell-associated localizations of plasminogen activators and plasminogen activator inhibitor-1 in cultured endothelium. Exp Mol Pathol 1991 55 : 105 118.
21. Buko AM, Kentzer EJ, Petros A, Menon G, Zuiderweg ER, Sarin VK. Characterization of a posttranslational fucosylation in the growth factor domain of urinary plasminogen activator. Proc Natl Acad Sci USA 1991 88 : 3992 3996.
22. Klinger KW, Winqvist R, Riccio A et al. Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis. Proc Natl Acad Sci USA 1987 84 : 8548 8552.
23. Kornman KS, Crane A, Wang H-Y et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997 24 : 72 77.
24. Schroder NW, Meister D, Wolff V et al. Chronic periodontal disease is associated with single-nucleotide polymorphisms of the human TLR-4 gene. Genes Immun 2005 6 : 448 451.
25. Kinane DF, Hart TC. Genes and gene polymorphisms associated with periodontal disease. Crit Rev Oral Biol Med 2003 14 : 430 449.
26. Bernick S, Levy BM, Patek PR. Studies on the biology of the periodontium of marmosets. VI. Arteriosclerotic changes in the blood vessels of the periodontium. J Periodont 1969 40 : 355 358.
27. Zoellner H, Hunter N. The vascular response in chronic periodontitis. Aust Dent J 1994 39 : 93 97.
28. Listgarten MA, Ricker FH, Laster L, Shapiro J, Cohen DW. Vascular basement lamina thickness in the normal and inflamed gingiva of diabetics and non-diabetics. J Periodont 1974 45 : 676 684.
29. Frantzis TG, Reeve CM, Brown AL. The ultrastructure of capillary basement membranes in the attached gingiva of diabetic and nondiabetic patients with periodontal disease. J Periodont 1971 42 : 406 411.
30. Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 1999 48 : 1899 1906.
31. Ogura N, Tobe M, Tamaki H, Nagura H, Abiko Y. IL-1beta increases uPA and uPA receptor expression in human gingival fibroblasts. IUBMB Life 2001 51 : 381 385.